ARCHIVES

DCT Board Okay Recompetitions, Delays Decision On Clonogenic Assays

This article is from The Cancer Letter archive.

Vol. 09 No. 25 | June 24, 1983

Download PDF Visit The Full Archive

Related Articles

In Brief: Kennedy’s Oversight Hearings Will Include Cancer Program, Important To Act Renewal

January 26, 1979

Committee Unblinds Phase III Zytiga Study

March 30, 2012

Interview: A Conversation with Robert Carlson

October 5, 2012

AMC Cancer Center, Rose Cancer Program Name Douglass Tormey Director; ECG Plans Move To Denver

September 4, 1992

December Business & Regulatory Report included in this issue.

December 12, 2003

FDA Issues Final Regs for Mammography Facilities, Personnel

November 7, 1997